Results 11 to 20 of about 135,734 (280)
Cardiac sarcoidosis (CS) is a rare inflammatory disorder characterised by the presence of non-caseating granulomas within the myocardium. Contemporary studies have revealed that 25–30% of patients with systemic sarcoidosis have cardiac involvement, with ...
Joseph Okafor +3 more
doaj +1 more source
Sarcoidosis is an inflammatory disorder of unknown cause that is characterized by granuloma formation in affected organs, most often in the lungs. Patients frequently suffer from cough, shortness of breath, chest pain and pronounced fatigue and are at risk of developing lung fibrosis or irreversible damage to other organs.
Grunewald, Johan +5 more
openaire +6 more sources
Background: Inspired by intense challenges encountered by patients and clinicians, we examined the experiences of living with sarcoidosis in three of the hardest impacted English-speaking cities during the early COVID-19 pandemic: London, New Orleans ...
Lesley Ann Saketkoo MD, MPH +14 more
doaj +1 more source
Sarcoidosis lung transplantation waitlist mortality, a national registry database study
Background The Lung Allocation Score (LAS) prioritises lung transplantation candidates, balancing waitlist mortality and post-transplant survival. The score groups sarcoidosis candidates based on mean pulmonary artery pressure: those with ≤30 mmHg ...
Derlis C. Fleitas Sosa +9 more
doaj +1 more source
Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study
Background Pirfenidone slows down disease progression in idiopathic pulmonary fibrosis (IPF). Recent studies suggest a treatment effect in progressive pulmonary fibrosis other than IPF.
Jelle R. Miedema +7 more
doaj +1 more source
Background Treatment of pulmonary sarcoidosis is recommended in case of significant symptoms, impaired or deteriorating lung function. Evidence-based treatment recommendations are limited and largely based on expert opinion.
Vivienne Kahlmann +10 more
doaj +1 more source
Background and Objectives: It is still unclear whether sarcoidosis is likely to be associated with tumors. In addition, the use of an immune checkpoint inhibitor has been reported to initiate the onset of sarcoidosis.
Yoshimasa Hachisu +11 more
doaj +1 more source
Nodular Sarcoidosis Masquerading as Cancer. [PDF]
Nodular lung disease is a rare pulmonary manifestation of sarcoidosis and resembles metastatic neoplasm disease. Nodular sarcoidosis is rare, varying from 1.6% to 4% of patients with sarcoidosis.
Singh, Navneet K +3 more
core +2 more sources
Research progress on drug treament for sarcoidosis [PDF]
Sarcoidosis is a systemic disease characterized by non-caseous epithelioid cell granuloma,which can involve with multiple organs,especially the lung. Sarcoidosis is characterized by diverse clinical manifestations and high incidence rate.
Luo Cheng, Wu Cong, Wang Yuguang
doaj +1 more source
Sarcoidosis-associated hepatocellular carcinoma [PDF]
Sarcoidosis is a systemic granulomatous inflammation of unknown etiology, and seems to involve the liver parenchyma in most cases. However, sarcoidosis-associated hepatocellular carcinoma is rare. We report here a case in which a hepatocellular carcinoma
Aiko, Satoshi +7 more
core +1 more source

